查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466312

特种药品分销市场：按适应症、经销商类型、分销类型、最终用户分类 - 2024-2030 年全球预测

Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年专科药品分销市场规模为47.6亿美元，预计2024年将达54.7亿美元，2030年将达122.5亿美元，复合年增长率为14.44%。

特种药物通常是高成本药物，製造复杂，需要专门的处理、储存和运输才能保持有效性。分销管道至关重要，因为特种药物通常需要在整个供应链中进行特殊处理和储存。特殊药物可能很昂贵或难以取得，因此需要精心设计的分配策略，以确保及时、适当地为正确的患者提供服务。专科药品分销管道确保专科药品从製造商到批发商再到药房的顺畅流动，并在遵守安全标准的同时毫髮无伤、快速到达。透过利用有效的分配方法，医疗保健提供者可以满足必要的时间限制，同时确保特殊药物得到正确处理和安全运输。强大的配送系统提供了额外的安全层，以确保整个供应链符合这些温度要求。然而，管理各种分销管道和药物资料的复杂性，以及处理特殊药物的法律规范，限制了市场的成长。同时，专业药房的扩张以及新的进步和技术，例如用于无缝专业药物配送的整合低温运输管理和追踪系统，正在提高专业药物配送的效率、安全性和整体患者体验。

主要市场统计
基准年[2023] 47.6亿美元
预测年份 [2024] 54.7亿美元
预测年份 [2030] 122.5亿美元
复合年增长率（%） 14.44%

适应症疾病：癌症治疗对专用药物的需求不断增加

特殊药物分销涉及需要特殊药物的各种疾病和病症。这些药物对于治疗后天免疫力缺乏症候群 (AIDS)、血友病、多发性硬化症、癌症和类风湿性关节炎(RA) 等疾病至关重要。特殊药物也可用于治疗各种其他疾病，包括罕见遗传疾病、器官移植和皮肤病。具体的药物和治疗方法将根据疾病、患者需求以及医学研究和创新的进展而有所不同。

经销商类型：特种药品全线批发商的数量不断增加

全线批发商向零售商和客户提供处方笺药、补充品药物和特殊药物分销服务。此外，我们还提供温控设施、供应解决方案、仓储解决方案和物流服务，以有效管理特殊药品供应链。特种药品经销商为药品製造商分销治疗爱滋病、癌症、类风湿性关节炎和多发性硬化症等重要疾病的药品提供关键支持。特种药品经销商已根据监管机构严格的储存和运输指南建立了储存和分销特种药品的基础设施。

分销类型：大量渗透到专业药房

医院药局提供专业服务，如配药、特殊药物配送、有限送货上门和药物治疗管理。独立药房专注于客户服务，为慢性病提供特殊药物，为患者提供量身定制的护理和个人关注。与独立药局相比，大型连锁药局拥有广泛的专业药品储存基础设施，确保药品的有效配送。网路商店是一种基于网路的业务，允许消费者从各种来源在线购买药品，透过快速运输选项和轻鬆获取多种专业药品提供便利。专业药局专注于为癌症、爱滋病毒/爱滋病、C型肝炎、类风湿性关节炎和多发性硬化症等复杂疾病提供药物和治疗方法。由于特殊药物的关键储存和处理要求，特殊药房建立了储存设施。通讯药房透过直接从药房或透过远端合作伙伴网路透过邮寄或电话订购方便地提供特殊药物，从而确保特种药物的有效分发。

最终使用者：家庭环境中特种药物分配的新可能性

专业药品分销为医疗保健生态系统中的各种最终用户提供服务，包括医疗付款人、医院/诊所、家庭环境和门诊手术中心。医疗保险公司、药品福利管理机构 (PBM) 和政府计划等医疗保健支付者在特殊药物分配中协商特殊药物定价、报销和承保政策，以确保患者的可及性和可负担性发挥重要作用。医疗机构提供住院和门诊病人特殊药物，在医疗专业人员的监督下向患者给药，以治疗癌症、自体免疫疾病和罕见疾病等复杂的医疗状况。居家医疗提供者和熟练的护理服务人员的任务是在患者家中提供和管理特殊药物，为患者提供所需的护理便利，同时最大限度地减少医院就诊次数。此外，门诊手术中心 (ASC) 为特定手术或当日手术的术后护理提供药物。特种药品分销公司与这些最终用户密切合作，确保及时有效地供应特殊药品，以满足患者的需求。

区域洞察

由于美国是美国、加拿大、巴西和其他国家的药品製造地的所在地，因此特种药物分销的环境复杂且快速变化。这些国家建立了製药工业和基础设施来支持特殊药物的生产和分销。该地区的特殊药物分销由加拿大卫生署食品药物管理局(FDA) 管理，负责监管药物（包括特殊药物）的核准、製造标准和分销，并确保符合 Masu 的品质和安全标准。此外，中国、印度、日本、韩国、澳洲等国家拥有强大的药品製造能力，也正在增加对特色药品研发的投入。这种增长促进了亚太地区专科药品分销监管框架的发展以及专科药品分销网络的扩展。欧洲、中东和非洲已经建立了药品（包括特种药品）的法律规范。欧洲的欧洲药品管理局 (EMA)、沙乌地阿拉伯的沙乌地食品管理局 (SFDA) 和南非的药品管制委员会 (MCC) 是监督药品核准、品质标准和分销实践的监管机构。此外，健康保险公司和政府计划等付款人因国家而异，报销模式和获取政策也各不相同，这影响了特种药物的分配和可负担性。

FPNV定位矩阵

FPNV 定位矩阵对于评估专业药品分销市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市场占有率分析

市场占有率分析是一种综合工具，可以对专业药品分销市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析也为此细分市场的竞争特征提供了宝贵的见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：包括新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：包括对未来技术、研发活动和突破性产品开发的智力见解。

本报告解决了以下关键问题：

1.专科药品分销市场的市场规模与预测为何？

2.在专业药品分销市场的预测期内，我们应该考虑投资哪些产品和应用？

3.专科药品分销市场的技术趋势和法规结构是什么？

4.专业药品分销市场主要供应商的市场占有率为何？

5.进入专科药品流通市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 增加特种药物开发平臺和交易
      • 专注于优化药品成本、供应和存储，提供以患者为中心的护理
    • 抑制因素
      • 管理各种分销管道的复杂性
    • 机会
      • 专科药品分销新技术的整合与推进
      • 专业药局正在世界各地扩张
    • 任务
      • 与特殊药物处理相关的法规结构的变化
  • 市场区隔分析
    • 适应症：对治疗肿瘤疾病的专用药物的需求不断增加
    • 经销商类型：特种药品的全线批发商日益增加。
    • 分销型态：专科药局渗透率高
    • 最终用户：家庭环境中专业药品分配的新可能性
  • 市场趋势分析
    • 采用新的数位生态系统，专注于改善美洲特种药物的分销
    • 专注于扩大亚太地区的特殊药品分销网络
    • 政府对罕见疾病管理的措施和成熟的製药公司推动了市场成长
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章 专科药品流通市场：依适应症分类

  • 介绍
  • 爱滋病
  • 血友病
  • 多发性硬化症
  • 肿瘤学
  • 类风湿性关节炎

第七章 专业药品分销市场：经销商类型

  • 介绍
  • 全线批发商
  • 专业经销商

第八章 专业药品分销市场：依分销类型

  • 介绍
  • 医院/诊所药房
  • 独立药房
  • 大型连锁药房
  • 通讯药房
  • 网路商店
  • 专业药房

第九章 专业药品分销市场：依最终用户分类

  • 介绍
  • 门诊手术中心
  • 医疗付款人
  • 居家医疗
  • 医院/诊所

第十章美洲专业药品经销市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区特种药品分销市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的特用药品分销市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-43192CEFCC35

[190 Pages Report] The Specialty Drug Distribution Market size was estimated at USD 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030.

Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized handling, storage, and transport to maintain efficacy. The distribution channels are essential for specialty drugs, as they often require special handling and storage throughout the supply chain. Specialty drugs are expensive or hard to obtain; thus, a well-designed distribution strategy is necessary to ensure timely and proper access to the right patients. A distribution channel for specialty drugs allows for a smooth flow of specialty drugs from the manufacturer through the wholesaler to the pharmacy, ensuring that they arrive intact and promptly while adhering to safety standards. By utilizing effective distribution methods, healthcare providers can ensure that specialty drugs are properly handled and safely transported while meeting necessary time-sensitive requirements. Robust distribution systems provide an extra layer of safety to guarantee that these temperature requirements are met throughout the supply chain. However, the complexity of managing different distribution channels and drug data and dynamic regulatory frameworks for specialty drug handling restricts the market growth. On the other hand, the rising expansion of specialty pharmacies and new advancements and technologies, including cold chain management and track & trace systems, among others, integrated for the seamless distribution of the specialty drug is aiming at enhancing the efficiency, safety, and overall patient experience in the distribution of specialty drugs.

KEY MARKET STATISTICS
Base Year [2023] USD 4.76 billion
Estimated Year [2024] USD 5.47 billion
Forecast Year [2030] USD 12.25 billion
CAGR (%) 14.44%

Disease Indication: Escalated need of specialty drugs to treat oncology conditions

Specialty drug distribution caters to various diseases and medical conditions requiring specialized medications. These drugs are crucial in treating acquired immunodeficiency syndrome (AIDS), hemophilia, multiple sclerosis, oncology, and rheumatoid arthritis (RA). Specialty drugs are distributed for a wide range of other medical conditions, including rare genetic disorders, organ transplantation, dermatological conditions, and more. The specific drugs and treatments vary based on the disease, patient needs, and advancements in medical research and innovation.

Distributor Type: Rising presence of full line wholesalers of speciality drugs

Full-line wholesalers provide distribution services for prescription drugs, supplement drugs, and specialty pharmaceuticals to retailers and customers. Additionally, they provide temperature control facilities, supply solutions, warehousing solutions, and logistics services to manage the specialty drugs supply chain effectively. Specialty distributors critically support drug manufacturers in distributing drugs for critical diseases such as AIDS, cancer, rheumatoid arthritis, and multiple sclerosis. Specialty distributors have established infrastructure for storing and distributing specialty drugs according to regulatory agencies' stringent storage and transportation guidelines.

Distribution Type: Significant penetration in specialty pharmacies

Hospital pharmacies offer specialized services such as compounding, specialty drug distribution, limited home delivery, and medication therapy management. Independent pharmacies focus on customer service by offering specialty drugs for chronic diseases to provide personalized patient care and individualized attention. Large chain pharmacies have vast infrastructure for the storage of specialty drugs compared to independent pharmacies, ensuring effective distribution of drugs. Online stores are web-based operations that allow consumers to purchase medications from various sources online, offering convenience by providing quick delivery options and easy access to a wide selection of specialty medications. Specialty pharmacies are focused on providing medicines and treatments for complex diseases such as cancer, HIV/AIDS, hepatitis C, rheumatoid arthritis, and multiple sclerosis. Specialty pharmacies have established storage facilities owing to critical storage and handling requirements of specialty drugs. Mail-order pharmacies provide convenient access to specialty medications via mail or telephone orders directly from a pharmacy or through a network of affiliated partners in remote areas to ensure the effective distribution of specialty drugs.

End-User: Emerging potential for specialty drug distribution in home settings

Specialty drug distribution serves various end-users in the healthcare ecosystem, including healthcare payers, hospitals & clinics, home settings, and ambulatory surgical centers. Healthcare payers, including health insurance companies, pharmacy benefit managers (PBMs), and government programs, play a crucial role in specialty drug distribution to negotiate pricing, reimbursement, and coverage policies for specialty drugs, ensuring access and affordability for patients. Healthcare facilities receive specialty drugs for inpatient and outpatient settings, where they are administered to patients under the supervision of medical professionals to treat complex medical conditions, such as cancer, autoimmune disorders, and rare diseases. Home healthcare providers and specialized nursing services play a role in delivering and administering specialty drugs to patients in their homes to provide convenience and allow patients to receive necessary treatment while minimizing hospital visits. Moreover, in ambulatory surgical centers (ASCs), the drugs are supplied for specific procedures or to manage post-operative care on same-day surgical procedures. Specialty drug distribution companies work closely with these end-users to ensure timely and efficient delivery of specialty drugs to meet patient needs.

Regional Insights

America's landscape for specialty drug distribution is complex and rapidly evolving, as the region has several prominent pharmaceutical manufacturing hubs, including the United States, Canada, and Brazil. These countries have well-established pharmaceutical industries and infrastructure to support the production and distribution of specialty drugs. Specialty drug distribution in the region is governed by the Food and Drug Administration (FDA), Health Canada, which regulates the approval, manufacturing standards, and distribution of pharmaceuticals, including specialty drugs, and ensures compliance with quality and safety standards. Furthermore, countries such as China, India, Japan, South Korea, and Australia have robust pharmaceutical manufacturing capabilities and are increasingly investing in research and development of specialty drugs. This growth has led to expanding specialty drug distribution networks in the APAC region with their regulatory framework governing the distribution of specialty drugs. The EMEA region has a well-established regulatory framework for pharmaceuticals, including specialty drugs. The European Medicines Agency (EMA) in Europe, the Saudi Food and Drug Authority (SFDA) in Saudi Arabia, and the Medicines Control Council (MCC) in South Africa are some of the regulatory bodies that supervise the approval, quality standards, and distribution practices for pharmaceutical products. Moreover, the payers, such as health insurance companies and government programs, vary across countries, with different reimbursement models and access policies influencing the distribution and affordability of specialty drugs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Specialty Drug Distribution Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Specialty Drug Distribution Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Accredo Health Group, Inc., AmerisourceBergen Corporation, BioCare, Inc., Cardinal Health, Inc., Centene Corporation, China National Pharmaceutical Group Corporation, CVS Specialty, Inc. by CVS Health Corporation, Elevance Health, Inc., Eversana, Feron Healthcare Pvt Ltd., FFF Enterprises Inc., Kroger Specialty Pharmacy, Lifeline Pharmaceuticals, LLC, Marken by United Parcel Service, Inc., McKesson Corporation, Medipal Holdings Corporation, Medis Intago, d.o.o., Morris & Dickson Co., LLC, Optum, Inc., PHOENIX Pharmahandel GmbH & Co KG, Shanghai Pharmaceuticals Group Co., Ltd., Shields Health Solutions Holdings, LLC, Sun Pharmaceutical Industries Limited, Suzuken Co., Ltd., Teva Pharmaceutical Industries Ltd., and Walmart Inc..

Market Segmentation & Coverage

This research report categorizes the Specialty Drug Distribution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Disease Indication
    • AIDS
    • Hemophilia
    • Multiple Sclerosis
    • Oncology
    • Rheumatoid Arthritis
  • Distributor Type
    • Full line Wholesalers
    • Specialty Distributors
  • Distribution Type
    • Hospitals & Clinic Pharmacies
    • Independent Pharmacies
    • Large Chain Pharmacies
    • Mail-Order Pharmacies
    • Online Stores
    • Specialty Pharmacies
  • End-User
    • Ambulatory Surgical Centers
    • Healthcare Payers
    • Home Settings
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Specialty Drug Distribution Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Specialty Drug Distribution Market?

3. What are the technology trends and regulatory frameworks in the Specialty Drug Distribution Market?

4. What is the market share of the leading vendors in the Specialty Drug Distribution Market?

5. Which modes and strategic moves are suitable for entering the Specialty Drug Distribution Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing specialty drug development pipeline and trade
      • 5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
    • 5.1.2. Restraints
      • 5.1.2.1. Complexity in managing different distribution channels
    • 5.1.3. Opportunities
      • 5.1.3.1. New technology integration and advancements in specialty drug distribution
      • 5.1.3.2. Rising expansion of specialty pharmacies worldwide
    • 5.1.4. Challenges
      • 5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Disease Indication: Escalated need of specialty drugs to treat oncology conditions
    • 5.2.2. Distributor Type: Rising presence of full line wholesalers of speciality drugs
    • 5.2.3. Distribution Type: Significant penetration in specialty pharmacies
    • 5.2.4. End-User: Emerging potential for specialty drug distribution in home settings
  • 5.3. Market Trend Analysis
    • 5.3.1. Introduction of new digital ecosystems focusing on improving the distribution of specialty drugs in the Americas
    • 5.3.2. Focus on specialty drug distribution network expansion in the Asia-Pacific region
    • 5.3.3. Government initiatives for rare disease management and well-established pharma companies expand the market growth
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis

6. Specialty Drug Distribution Market, by Disease Indication

  • 6.1. Introduction
  • 6.2. AIDS
  • 6.3. Hemophilia
  • 6.4. Multiple Sclerosis
  • 6.5. Oncology
  • 6.6. Rheumatoid Arthritis

7. Specialty Drug Distribution Market, by Distributor Type

  • 7.1. Introduction
  • 7.2. Full line Wholesalers
  • 7.3. Specialty Distributors

8. Specialty Drug Distribution Market, by Distribution Type

  • 8.1. Introduction
  • 8.2. Hospitals & Clinic Pharmacies
  • 8.3. Independent Pharmacies
  • 8.4. Large Chain Pharmacies
  • 8.5. Mail-Order Pharmacies
  • 8.6. Online Stores
  • 8.7. Specialty Pharmacies

9. Specialty Drug Distribution Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Healthcare Payers
  • 9.4. Home Settings
  • 9.5. Hospital & Clinics

10. Americas Specialty Drug Distribution Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Specialty Drug Distribution Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Specialty Drug Distribution Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH, the First FDA Approved Treatment for Molluscum Contagiosum
    • 13.3.2. Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease
    • 13.3.3. Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries
    • 13.3.4. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
    • 13.3.5. Elevance Health Announces Closing of BioPlus Acquisition
    • 13.3.6. CVS Health to acquire Oak Street Health
    • 13.3.7. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
    • 13.3.8. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
    • 13.3.9. Prime Therapeutics Closes USD 1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy and Medical Drug Management Expertise
    • 13.3.10. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
    • 13.3.11. Manulife and Shoppers Drug Mart Collaborate to Help Manage Serious Medical Conditions
    • 13.3.12. Marken Reaches Agreement to Acquire the Medical Courier Business of Cedra Express, Expands Direct Presence in New Zealand
    • 13.3.13. Cardinal Health Continues to Expand at-Home Solutions Business
    • 13.3.14. Halozyme to Acquire Antares Pharma for Around USD 960 Million

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
  • FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
  • FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 60. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 61. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 62. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 92. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 93. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 94. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 95. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 100. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 111. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 112. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 113. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 124. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 125. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 128. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 129. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 132. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 133. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 136. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 137. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 148. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 149. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 152. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 153. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 160. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 161. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 164. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 165. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 184. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 188. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 189. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 192. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 193. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 217. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 222. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 223. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 226. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 227. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 230. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 231. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 234. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 235. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 236. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 237. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 246. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 247. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 250. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 251. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 254. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 255. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 258. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 259. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 260. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 261. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 274. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 278. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 282. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 283. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 284. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 285. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 290. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 291. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 292. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 293. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 294. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 295. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 296. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 297. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 298. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 299. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 302. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 303. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 304. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 305. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
  • TABLE 306. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
  • TABLE 307. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
  • TABLE 308. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
  • TABLE 309. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 310. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 311. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 312. QATAR SP